Exchange: NASDAQ·Updated 07:56 PM EDT
ZBIO logo

ZBIOZenas Biopharma Inc.

$32.36
$1.66
(5.41%)
Today
Closed $32.36
$0.02
(0.06%)
After Hours
EarningsAug 12
Mkt Cap$1.94B
Vol1.63M
News
all
press releases
Zenas BioPharma's CEO Purchased 60,000 Company Shares. Here's a Deeper Look at the Transaction.
Key PointsCEO Leon Moulder acquired 60,000 shares for a total value of approximately $1.01 million on May 18, 2026...
Nasdaq News: Markets
More News
Tuesday 5/19 Insider Buying Report: ZBIO, ICFI
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On Monday, Zenas Biopharma's Chief Executive Officer, Leon O. Moulder Jr., made a...
Nasdaq News: Markets
Zenas BioPharma (NASDAQ:ZBIO) Stock Price Up 7.7% - Still a Buy?
Zenas BioPharma (NASDAQ:ZBIO) Shares Up 7.7% - Should You Buy...
MarketBeat
Thursday 4/30 Insider Buying Report: ZBIO, PDX
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At Zenas Biopharma, a filing with the SEC revealed that on Wednesday, Chief Executi...
Nasdaq News: Markets
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap Up on Insider Buying Activity
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap Up on Insider Buying Activity...
MarketBeat
Leon Moulder, Jr. Buys 25,000 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. purchased 25,000 shares of the company's stock in a transaction that occurred on Tuesday, April 28th. The shares were...
MarketBeat
Zenas BioPharma (NASDAQ:ZBIO) CEO Acquires $616,700.00 in Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. bought 35,000 shares of the stock in a transaction on Wednesday, April 29th. The stock was purchased at an average cost of...
MarketBeat
Leon Moulder Jr Purchases 25,000 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. purchased 25,000 shares of the stock in a transaction that occurred on Tuesday, April 28th. The shares were acquired at an...
MarketBeat
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Given Average Rating of "Hold" by Analysts
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) has been given an average rating of "Hold" by the nine brokerages that are presently covering the firm, Marketbeat reports. Two investment...
MarketBeat
Zenas BioPharma (NASDAQ:ZBIO) Issues Quarterly Earnings Results
Zenas BioPharma (NASDAQ:ZBIO - Get Free Report) posted its earnings results on Monday. The company reported ($1.10) earnings per share (EPS) for the quarter...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.